# US 2003/0216324 A1 · Airway mucus secretion inhibitors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0216324 A1
- Document ID: US20030216324A1
- Status: Published application
- Kind: A1
- Application number: 10/381,723
- Filed: 2003-03-28
- Published: 2003-11-20
- Earliest claimed: 2000-09-29
- Inventors: Atsushi Nagai; Takamitsu Shiraji
- Web page: https://patentgrep.com/patent/US20030216324A1

## CPC

- C07D 413/12: linked by a chain containing hetero atoms as chain links
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61K 31/4245: Oxadiazoles
- A61K 31/4355: the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
- A61K 31/4365: the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
- A61K 31/437: the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A61K 31/4439: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465)
- A61K 31/47: Quinolines; Isoquinolines
- A61K 31/4725: containing further heterocyclic rings
- A61K 31/513: having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 31/55: having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K 31/551: having two nitrogen atoms, e.g. dilazep
- A61K 31/5513: 1,4-Benzodiazepines, e.g. diazepam {or clozapine}
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 11/06: Antiasthmatics
- A61P 11/12: Mucolytics
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 487/06: Peri-condensed systems
- C07K 5/0202: {containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids}
- C07K 5/0808: {the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu}
- C07K 5/0821: {with the first amino acid being heterocyclic, e.g. His, Pro, Trp}
- C07K 5/0827: {containing heteroatoms different from O, S, or N}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Prophylactic and/or therapeutic drugs against diseases with the augmentative airway mucus secretion, which include five-member heterocyclic compounds represented by the formula (I) or these nontoxic salts as active principle, 1 (wherein Z represents the group containing α-aminocarbonyl group, R1 represents (1) substituted alkyl, alkenyl or alkynyl groups, (2)OH, (3)amino, (4)alkylamino, (5)dialkylamino, etc., X and Y represent oxygen atom, sulfur atom or substituted nitrogen atom.)

## Claims

### Claim 1

Prophylactic and/or therapeutic drugs for diseases with the augmentative airway mucus secretion, which include five-member heterocyclic compounds represented by the formula (I) or these nontoxic salts as active principle,
82
(wherein Z represents the group to contain α-aminocarbonyl group that carbonyl carbon atom combines with carbon atom of heterocyclic group through covalent bond,
R1 represents
(1) alkyl, alkenyl or alkynyl groups, with the proviso that these groups may be substituted with one or more groups chosen from (a)halogen atom, (b)hydroxy, (c)cyano, (d)nitro, (e)haloalkyl, (f)alkylamino, (g)dialkylamino (h)alkoxy, (i)haloalkoxy, (j)carboxy, (k)carboalkoxy, (l)alkylcaroxamide, (m)arylcaroxamide or (n)—O-(C5-C6) aryl groups,
(2)hydroxy,
(3)amino,
(4)alkylamino,
(5)dialkylamino, or
(6)cycloalkyl, alkylcycloalkyl, alkenylcycloalkyl, cycloalkenyl, alkylcycloalkenyl, alkenylcycloalkenyl, (C5-C12)aryl, (C5-C12)arylalkyl, (C5-C12)arylalkenyl, condensable (C5-C12)aryl-cycloalkyl or alkyl condensable (C5-C12)aryl-cycloalkyl, with the proviso that these groups may be substituted with groups chosen from (a)halogen atom, (b)hydroxy, (c)cyano, (d)nitro, (e)haloalkyl, (f)amino, (g)aminoalkyl, (h)dialkylamino, (i)alkyl, (j)alkenyl, (k)alkylenedioxy, (l)alkynyl, (m)alkoxy, (n)haloalkoxy, (o)carboxy, (p)carboalkoxy, (q)carboxamide, (r)(C5-C6)aryl, (s)—O-(C5-C6)aryl, (t)arylcarboxamide, (u)alkylthio or (v)haloaklylthio that may include 1-4 of hetero atoms chosen from nitrogen, oxygen or sulfur atom, respectively,
X and Y each independently represent oxygen, sulfur, nitrogen or atom,
which nitrogen atom may be substituted with groups chosen from
(1)alkyl or alkenyl that may be substituted with 1-3 of halogen atom,
(2)alkynyl,
(3)(C5-C6)aryl, arylalkyl, arylalkenyl that may include 1-3 of hetero atoms chosen from nitrogen, oxygen or sulfur atom or may be substituted with groups chosen from (a)halogen atom, (b)cyano, (c)nitro, (b)hydroxy, (e)haloalkyl, (f)amino, (g)aminoalkyl, (h)dialkylamino, (i)alkyl, (j)alkenyl, (k)alkynyl, (l)alkoxy, (m)haloalkoxy, (n)carboxy, (o)carboalkoxy, (p)carboxamide, (q)arylcarboxamide, (r)alkylthio or (s)haloaklylthio).

### Claim 2 (depends on 1)

Prophylactic and/or therapeutic drugs described in claim 1 wherein Z is represented by the formula (I-1),
83
(wherein R2 and R3 each independently represent alkyl, alkenyl, —RCOR′, —RCOOR′, —RNR′R′Ro, or —RC(O)NR′R″[wherein R represents alkyl or alkenyl, R′, R″ and Ro each independently represent hydrogen atom, alkyl, alkenyl, cycloalkyl or (C5-C6)aryl.] with the proviso that the above groups optionally be substituted with hydrogen, 1-3 of halogen atom, hydroxy, sulfur atom, alkylthio, amino, alkylamino, dialkylamino, alkylguanidinyl, dialkylguanidinyl, guanidinyl or amidylguanidine; or cycloalkyl, alkylcycloalkyl, alkenylcycloalkyl, alkyl-oxyaryl, alkyl-thioaryl, alkyl-aminoaryl, (C5-C12)aryl, (C5-C12)arylalkyl or (C5-C12)arylalkenyl with the proviso that the above groups optionally include 1-4 of hetero atoms chosen from nitrogen, oxygen or sulfur atom and are substituted with halogen atoms, cyano, keto, nitro, hydroxy, haloalkyl, amino, aminoalkyl, dialkylamino, amidine, alkylamidine, dialkylamidine, alkyl, alkenyl, alkylenedioxy, alkynyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, (C5-C6)aryl, —O-(C5-C6)aryl, arylcarboxamide, alkylthio or haloalkylthio,
A1 represents direct coupling, —C(O)—, —NH—C(O)—, —S(O)2—, —NH—S(O)2—, —C(O)—, —C— or, for example, amino acids chosen from the following, amino acids aren't limited to these;
proline, isoleucine or cyclohexylalanine; cysteine, phenylalanine, homo-phenylalanine, dehydrophenylalanine, indoline-2-carboxylic acid with the proviso that the above amino acids optionally be substituted with alkyl, alkenyl or phenyl, and that sulfur atom optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, arylcarboxamide, alkylthio or haloalkylthio; tetrahydroisoquinoline-2-carboxylic acid which optionally be substituted in alkyl, alkenyl or phenyl, with the proviso that these groups optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, arylcarboxamide, alkylthio or haloalkylthiotryptophan; tryptophane, tyrosine, serine, threonine; histidine, methionine, valine, norvaline, norleucine or octahydroindole-2-carboxylic acid with the proviso that these amino acids optionally be substituted with alkyl or aryl; asparagine, glutamine, ornithine or lysine with the proviso that nitrogen atoms in side chains of these amino acids optionally be substituted with alkyl, alkenyl, alkynyl, alkoxyalkyl, alkylthioalkyl, alkylaminoalkyl, dialkylaminoalkyl, carboxyalkyl, alkoxyalkyl, alkylthioalkyl, alkylaminoalkyl, dialkylaminoalkyl, carboxyalkyl, alkoxycarbonylalkyl, aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl or alkyl condensed aryl-cycloalkyl and optionally include one or more hetero atoms chosen from nitrogen, oxygen or sulfur atom,
R4-1 represents cycloalkyl, alkylcycloalkyl, (C5-C12)aryl, (C5-C12)arylalkyl, condensed (C5-12)aryl-cycloalkyl or condensed alkyl(C5-C12)aryl-cycloalkyl with the proviso that these groups optionally include hydrogen atom, alkyl, alkenyl or alkynyl, one or more hetero atoms chosen from nitrogen, oxygen or sulfur atom, and optionally be substituted with alkyl, alkenyl, alkynyl, halogen atom, cyano, nitro, hydroxy, haloalkyl, alkoxy, amino, aminoalkyl, dialkylamino, carboxy, haloalkoxy, carboalkoxy, alkylcarboxamide, aryl, arylalkyl, arylcarboxamide, alkylthio or haloalkylthio).

### Claim 3 (depends on 1)

Prophylactic and/or therapeutic drugs described in claim 1 wherein Z is represented by the formula (I-2)
84
(wherein R2 and R3 represent the same meanings as aforesaid;
B2 represents —S(O)2—, —C(O)—, —OC(O)— or —CH2C(O)—;
R6−2 represents the following groups;
85 86
(wherein R′2 and R′3 represent the same meanings as R2 and R3;
R13-2 represents aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl, alkyl condensed aryl-cycloalkyl with the proviso that these groups optionally include hydrogen atom, alkyl, halogen atom, alkoxy, carboalkoxy, carboxy, alkylthio, amino, alkylamino, dialkylamino or one or more hetero atoms chosen from nitrogen, oxygen or sulfur atom, and optionally be substituted with halogen atom or alkyl;
R14-2-1 represents aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl, alkyl condensed aryl-cycloalkyl or aryloxycarboxamide with the proviso that these groups optionally include hydrogen atom, alkyl, alkenyl, amino, alkylamino, dialkylamino or one or more hetero atoms chosen from nitrogen, oxygen or sulfur atom, and optionally be substituted with alkyl, halogen atom, alkoxy, amino, alkylamino, dialkylamino, carboxy, alkenyl, alkynyl, haloalkoxy, carboalkoxy, alkylcarboxamide, aryl, arylalkyl, arylcarboxamide, arylalkylcarboxamide, alkylthio or haloalkylthio;
R15-2 represents aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl or alkyl condensed aryl-cycloalkyl with the proviso that these groups optionally include halogen atom, alkyl, halogen atom, alkoxy, carboalkoxy, carboxy, alkylthio, amino, alkylamino, dialkylamino or one or more hetero atoms chosen from nitrogen, oxygen or sulfur atom;
W2-1 represents oxygen or sulfur atom; carbon or nitrogen atom that optionally be substituted with hydrogen atom, alkyl or aryl;
[m-2] represents 0 or 1;
[n-2] represents 0 or 1;
D2 represents direct coupling or, for example, amino acids chosen from the following, amino acids aren't limited to these;
proline, isoleucine or cyclohexylalanine; cysteine, phenylalanine, homo-phenylalanine, dehydrophenylalanine, indoline-2-carboxylic acid with the proviso that the above amino acids optionally be substituted with alkyl, alkenyl or phenyl, and that sulfur atom optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, arylcarboxamide, alkylthio or haloalkylthio; tetrahydroisoquinoline-2-carboxylic acid which optionally be substituted in alkyl, alkenyl or phenyl, with the proviso that these groups optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, arylcarboxamide, alkylthio or haloalkylthiotryptophan; tryptophane, tyrosine, serine, threonine; histidine, methionine, valine, norvaline, norleucine or octahydroindole-2-carboxylic acid with the proviso that these amino acids optionally be substituted with alkyl or aryl; asparagine, glutamine, ornithine or lysine with the proviso that nitrogen atoms in side chains of these amino acids optionally be substituted with alkyl, alkenyl, alkynyl, alkoxyalkyl, alkylthioalkyl, alkylaminoalkyl, dialkylaminoalkyl, carboxyalkyl, alkoxyalkyl, alkylthioalkyl, alkylaminoalkyl, dialkylaminoalkyl, carboxyalkyl, alkoxycarbonylalkyl, aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl or alkyl condensed aryl-cycloalkyl and optionally include one or more hetero atoms chosen from nitrogen, oxygen or sulfur atom;
A2 represents direct coupling, —C(O)—, —NH—C(O)—, —S(O)2—, —NH—S(O)2—, —C(O)— or —C—;
R14-2-2 represents aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl or alkyl condensed aryl-cycloalkyl with the proviso that these groups optionally include hydrogen atom, alkyl, alkenyl, amino, alkylamino, dialkylamino or one or more hetero atoms chosen from nitrogen, oxygen or sulfur atom, and optionally be substituted with alkyl, halogen atom, alkoxy, amino, alkylamino, dialkylamino, carboxy, alkenyl, alkynyl, haloalkoxy, carboalkoxy, alkylcarboxamide, aryl, arylalkyl, arylcarboxamide, alkylthio or haloalkylthio;
W2-2 represents sulfur or oxygen atom;
R8-2 represents alkylamino dialkylamino or amino;
R9-2 represents hydrogen atom, alkyl or halogen atom)).

### Claim 4 (depends on 1)

Prophylactic and/or therapeutic drugs described in claim 1 wherein Z is represented by the formula (I-3),
87
(wherein R2 and R3 represent the same meanings as aforesaid,
R10-3 represents (C5-C6)aryl, (C5-C6)arylalkyl, (C5-C6)arylalkenyl, cycloalkyl, condensed aryl-cycloalkyl with the proviso that these groups optionally include one or more hetero atoms chosen from nitrogen, sulfur or non-peroxideone oxygen atom, and optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkenyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, alkylthio or haloalkylthio;
D3 represents direct coupling, —C(O)— or, for example, amino acids chosen from the following, amino acids aren't limited to these;
proline, isoleucine or cyclohexylalanine; cysteine, phenylalanine, homo-phenylalanine, dehydrophenylalanine, indoline-2-carboxylic acid with the proviso that the above amino acids optionally be substituted with alkyl, alkenyl or phenyl, and that sulfur atom optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, arylcarboxamide, alkylthio or haloalkylthio; tetrahydroisoquinoline-2-carboxylic acid which optionally be substituted in alkyl, alkenyl or phenyl, with the proviso that these groups optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, arylcarboxamide, alkylthio or haloalkylthiotryptophan; tryptophane, tyrosine, serine, threonine; histidine, methionine, valine, norvaline, norleucine or octahydroindole-2-carboxylic acid with the proviso that these amino acids optionally be substituted with alkyl or aryl; asparagine, glutamine, ornithine or lysine with the proviso that nitrogen atoms in side chains of these amino acids optionally be substituted with alkyl, alkenyl, alkynyl, alkoxyalkyl, alkylthioalkyl, alkylaminoalkyl, dialkylaminoalkyl, carboxyalkyl, alkoxyalkyl, alkylthioalkyl, alkylaminoalkyl, dialkylaminoalkyl, carboxyalkyl, alkoxycarbonylalkyl, aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl or alkyl condensed aryl-cycloalkyl and optionally include one or more hetero atoms chosen from nitrogen, oxygen or sulfur atom;
A3 represents direct coupling, —C(O)—, —NH—C(O)—, —S(O)2—, —NH—S(O)2—, —C(O)—, —S(O)2-NH—, OC(O)NH—, —OC(O)— or —C—;
R14-2 and R14-2-1 represent the same meanings as aforesaid).

### Claim 5 (depends on 1)

Prophylactic and/or therapeutic drugs described in claim 1 wherein Z is represented by the formula (I-4),
88
(wherein R2, R3, R′2 and R′3 represent the same meanings as aforesaid,
R11-4, R12-4 and E4 are constituted of monocyclic or dicyclic ring with the proviso that these rings include 5-10 atoms chosen from carbon, nitrogen, sulfur or oxygen atom and include one or more keto groups and optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkenyl, alkynyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, alkylcarboxamide, alkylthio or haloalkylthio; and represent cycloalkyl, alkylcycloalkyl, alkenylcycloalkyl, (C5-C12)aryl, (C5-C12)arylalkyl, ((C5-C12)arylalkyl)OC(O)NH— or (C5-C12)arylalkyl with the proviso that these groups optionally include one or more hetero atoms chosen from nitrogen, sulfur or non-peroxideone oxygen atom, and optionally be substituted with halogen atom, cyano, nitro, haloalkyl, amino, aminoalkyl, dialkylamino, alkyl, alkenyl, alkoxy, haloalkoxy, carboxy, carboalkoxy, —C(O)O(alkyl), —C(O)(alkyl), alkylcarboxamide, alkylthio or haloalkylthio).

### Claim 6 (depends on 5)

Prophylactic and/or therapeutic drugs described in claim 5 wherein R11-4, R12-4 and E4 are represented by the formula (I-4),
89
(wherein A4-1 represents the same meanings as A3,
V1-4-1, V2-4-1, V3-4-1 and V4-4-1 each independently represent carbon or nitrogen atom, in case V3-4-1 represents carbon atom, R13-4-1 represents hydrogen atom, alkyl, halogen atom, alkoxy, carboalkoxy, carboxy, alkylthio, amino, alkylamino, dialkylamino; aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl or alkyl condensed aryl-cycloalkyl with the proviso that these groups optionally include one or more hetero atoms chosen from nitrogen, sulfur or oxygen atom, and optionally be substituted with halogen atom or alkyl;
R14-4-1 represents hydrogen atom, alkyl, alkenyl, amino, alkylamino or dialkylamino; aryl, arylalkyl, cycloalkyl, alkylcycloalkyl, condensed aryl-cycloalkyl or alkyl condensed aryl-cycloalkyl, arylalkylcarbonyl or arylalkylcarboxamide with the proviso that these groups optionally include one or more hetero atoms chosen from nitrogen, sulfur or oxygen atom, and optionally be substituted with alkyl, halogen atom, alkoxy, amino, alkylamino, dialkylamino, carboxy, alkenyl, alkynyl, haloalkoxy, carboalkoxy, alkylcarboxamide, aryl, arylalkyl, arylcarboxamide, alkylthio or haloalkylthio).

### Claim 7 (depends on 1)

Prophylactic and/or therapeutic drugs described in claim 1 wherein compounds are selected from;
(1) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(2) (2S,5S)-4-oxo-amino-5-1,2,4,5,6,7-hexahydro-N-[(1S)-1-[[5-3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]azepino-[3,2,1]-indole-2-carboxamide,
(3) 2-[3[amino-2-oxo-5-phenyl-1,4-benzodiazepinyl]-N-1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(4) Methylsulfonyl-L-valyl-N-[(1S)-1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]-L-prolinamide,
(5) 2-[4-(R)-isopropyl-2,5-imidazolidinedione-1-yl]-N-[(1S)-1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(6) Benzyloxycarbonyl-L-valyl-N-[(1S)-1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]-L-prolinamide,
(7) 2-[3-(2-(morpholine-2-yl)ethyl)-4-phenyl-2,5-imidazolidinedione-1-yl]-N-[1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl] acetamide,
(8) 2-[4-methyl-4-(pyridine-2-yl)-2,5-imidazolidinedione-1-yl]-N-1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl] acetamide,
(9) 2-[(4S)-4-(2-methylpropyl)-2,5-imidazolidinedione-1-yl]-N-1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(10) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(α,α-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(11) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(α,α-dimethyl-3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(12) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1R)-1-[[5-(3-methylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(13) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-phenyl-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(14) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(15) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(α,α-dimethyl-3,4-methylenedioxybenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(16) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-benzyl-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(17) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-methyl-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(18) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(1-methylethyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(19) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-butyl-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(20) 2-[5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(21) 2-[5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(α,α-dimethylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(22) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(1-methylcyclopropyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(23) 2-[6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(24) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1R)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(25) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1R)-1-[[5-(α,α-dimethylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(26) 2-[6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(α,α-dimethylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(27) 2-[5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(1-methylcyclopropyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(28) 2-[5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[(1R)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(29) 2-[6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(30) 2-[6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[(1R)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(31) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(32) 2-[6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(1-methylcyclopropyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(33) 2-[6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(1-methylcyclopropyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(34) 2-[5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(35) 2-[6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(36) 2-[5-amino-6-oxo-2-(pyridine-3-yl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(37) 2-[5-amino-6-oxo-2-(pyridine-3-yl)-1,6-dihydro-1-pyrimidinyl]-N-[(1S)-1-[[5-(α,α-dimethylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(38) 2-[5-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(α,α-dimethyl-3,4-methylenedioxybenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(39) 2-[5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(α,α-dimethyl-3,4-methylenedioxybenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(40) 2-[6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(α,α-dimethyl-3,4-methylenedioxybenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(41) 2-[6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(α,α-dimethylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(42) 2-[6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(α,α-dimethylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(43) 2-[6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(α,α-dimethylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(44) Methoxycarbonyl-L-valyl-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]-L-prolinamide,
(45) Methoxycarbonyl-L-valyl-N-[(1S)-1-[[5-(α,α-dimethylbenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]-L-prolinamide,
(46) Methoxycarbonyl-L-valyl-N-[(1S)-1-[[5-(α,α-dimethyl-3,4-methylenedioxybenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]-L-prolinamide,
(47) 2-[5-methoxycarbonylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide,
(48) 1-[(3S)-(2-(t-butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(49) 1-[(3S)-(2-(1-methylethoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(50) 1-[(3S)-(2-(imidazole-5-ylcarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(51) 1-[(3S)-(2-[(1S)-1-(methoxycarbonylamino)-2-methylpropylcarbonyl]-1,2,3,4-tetrahydroisoquinoline-3-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(52) 1-[(3S)-(2-[(1S)-1-(pyridine-3-ylcarbonylamino)-2-methylpropylcarbonyl]-1,2,3,4-tetrahydroisoquinoline-3-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(53) 1-[(2S)-1-(t-butoxycarbonyl)-2,3-dihydroindole-2-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(54) 1-[(2S)-1-(2-methylethoxycarbonyl)-2,3-dihydroindole-2-yl]-N-[(11S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(55) 1-[(2S)-1-(imidazole-5-ylcarbonyl)-2,3-dihydroindole-2-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(56) 1-[(2S)-1-[(1S)-1-(methoxycarbonylamino)-2-methylpropylcarbonyl]-2,3-dihydroindole-2-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(57)1-[(2S)-1-[(1S)-1-(pyridine-3-ylcarbonylamino)-2-methylpropylcarbonyl]-2,3-dihydroindole-2-yl]-N-[(1S)-1-[[5-(t-butyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]carboxamide,
(58) 2-[5-methoxycarbonylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-[1-[[5-(α,α-dimethyl-3,4-methylenedioxybenzyl)-1,3,4-oxadiazole-2-yl]carbonyl]-2-methylpropyl]acetamide.

### Claim 8 (depends on 1)

Prophylactic and/or therapeutic drugs described in claim 1 wherein a disease with the augmentative airway mucus secretion is asthma.
